Victoza For Type 2 Diabetes With Moderate Renal Impairment Gets CHMP Recommendation
News, Type 2 Diabetes News
The Committee for Medicinal Products for Human Use (CHMP) reviewed data from a LIRA-RENAL phase 3b clinical trial and approved Victoza (liraglutide) for adults with type 2 diabetes and moderate renal ... Read more